Cargando…
Breakthrough in heart failure with preserved ejection fraction: are we there yet?
Heart failure with preserved ejection fraction (HFPEF) is a global health problem of considerable socioeconomic burden. It is projected to worsen with the aging population worldwide. The lack of effective therapies underscores our incomplete understanding of this complex heterogeneous syndrome. A no...
Autores principales: | Lim, Shir Lynn, Lam, Carolyn Su Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712413/ https://www.ncbi.nlm.nih.gov/pubmed/26767852 http://dx.doi.org/10.3904/kjim.2016.31.1.1 |
Ejemplares similares
-
Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction
por: Talha, Khawaja M., et al.
Publicado: (2022) -
EMPEROR-Preserved: SGLT2 inhibitors breakthrough in the management of heart failure with preserved ejection fraction
por: Wagdy, Kerolos, et al.
Publicado: (2021) -
Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013) -
Understanding heart failure with preserved ejection fraction: where are we today?
por: van Heerebeek, L., et al.
Publicado: (2016) -
Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)